🔎 Trials Near Me

Home › Macular Degeneration › Pennsylvania › Philadelphia

Macular Degeneration clinical trials in Philadelphia, PA

6 studies for Macular Degeneration are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RecruitingPhase 3
  • Mid Atlantic Retina, Wills Eye Hospital, Philadelphia
  • Vision Research Solutions - the Eye Institute, Philadelphia
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

RecruitingObservational study
  • Wills Eye Physicians - Mid Atlantic Retina, Philadelphia
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574

High Resolution Retinal Imaging

RecruitingObservational studyHealthy volunteers welcome
  • University of Pennsylvania, Philadelphia
Ages 7 and older · All sexes · Updated May 5, 2026 · NCT01866371

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

RecruitingPhase 1
  • CBCC Global Research Site:007, Philadelphia
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035

Novel Glaucoma Diagnostics

RecruitingObservational studyHealthy volunteers welcome
  • Wills Eye Hospital, Philadelphia
Ages 18 and older · All sexes · Updated Aug 15, 2024 · NCT00286637

About Macular Degeneration

Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.

More about Macular Degeneration on MedlinePlus

Macular Degeneration trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.